Sedative effects and serum drug concentrations of oxymorphone and metabolites after subcutaneous administration of a liposome-encapsulated formulation in dogs.

Source:http://linkedlifedata.com/resource/pubmed/id/15500576

Download in:

View as

General Info

PMID
15500576